These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 7585661)

  • 21. The beta-type transforming growth factor. Mediators of cell regulation in the lung.
    Pelton RW; Moses HL
    Am Rev Respir Dis; 1990 Dec; 142(6 Pt 2):S31-5. PubMed ID: 2174660
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Fibulin-3 is a novel TGF-β pathway inhibitor in the breast cancer microenvironment.
    Tian H; Liu J; Chen J; Gatza ML; Blobe GC
    Oncogene; 2015 Nov; 34(45):5635-47. PubMed ID: 25823021
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Loss of growth regulation by transforming growth factor-beta (TGF-beta) in human cancers: studies on endometrial carcinoma.
    Gold LI; Parekh TV
    Semin Reprod Endocrinol; 1999; 17(1):73-92. PubMed ID: 10406078
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Androgenic control of transforming growth factor-beta signaling in prostate epithelial cells through transcriptional suppression of transforming growth factor-beta receptor II.
    Song K; Wang H; Krebs TL; Kim SJ; Danielpour D
    Cancer Res; 2008 Oct; 68(19):8173-82. PubMed ID: 18829577
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Transforming growth factor-beta-related proteins: an ancestral and widespread superfamily of cytokines in metazoans.
    Herpin A; Lelong C; Favrel P
    Dev Comp Immunol; 2004 May; 28(5):461-85. PubMed ID: 15062644
    [TBL] [Abstract][Full Text] [Related]  

  • 26. TGF-beta receptors: structure and function.
    Lin HY; Moustakas A
    Cell Mol Biol (Noisy-le-grand); 1994 May; 40(3):337-49. PubMed ID: 7920178
    [TBL] [Abstract][Full Text] [Related]  

  • 27. How cells read TGF-beta signals.
    Massagué J
    Nat Rev Mol Cell Biol; 2000 Dec; 1(3):169-78. PubMed ID: 11252892
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Molecular mechanism of inactivation of TGF-beta receptors during carcinogenesis].
    Kim SJ
    Tanpakushitsu Kakusan Koso; 2001 Feb; 46(2):111-6. PubMed ID: 11211784
    [No Abstract]   [Full Text] [Related]  

  • 29. TGFbeta signaling and cancer.
    Hata A
    Exp Cell Res; 2001 Mar; 264(1):111-6. PubMed ID: 11237527
    [No Abstract]   [Full Text] [Related]  

  • 30. APPL proteins promote TGFβ-induced nuclear transport of the TGFβ type I receptor intracellular domain.
    Song J; Mu Y; Li C; Bergh A; Miaczynska M; Heldin CH; Landström M
    Oncotarget; 2016 Jan; 7(1):279-92. PubMed ID: 26583432
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Transforming growth factor -beta receptor signaling in cancer.
    Narayan S; Thangasamy T; Balusu R
    Front Biosci; 2005 May; 10():1135-45. PubMed ID: 15769612
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Alterations in components of the TGF-beta superfamily signaling pathways in human cancer.
    Levy L; Hill CS
    Cytokine Growth Factor Rev; 2006; 17(1-2):41-58. PubMed ID: 16310402
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Transforming growth factor-beta response and expression in junctional and oral gingival epithelial cells.
    Lu H; Mackenzie IC; Levine AE
    J Periodontal Res; 1997 Nov; 32(8):682-91. PubMed ID: 9409464
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Epigenetic inactivation of Betaig-h3 gene in human cancer cells.
    Shao G; Berenguer J; Borczuk AC; Powell CA; Hei TK; Zhao Y
    Cancer Res; 2006 May; 66(9):4566-73. PubMed ID: 16651406
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Somatic acquisition and signaling of TGFBR1*6A in cancer.
    Pasche B; Knobloch TJ; Bian Y; Liu J; Phukan S; Rosman D; Kaklamani V; Baddi L; Siddiqui FS; Frankel W; Prior TW; Schuller DE; Agrawal A; Lang J; Dolan ME; Vokes EE; Lane WS; Huang CC; Caldes T; Di Cristofano A; Hampel H; Nilsson I; von Heijne G; Fodde R; Murty VV; de la Chapelle A; Weghorst CM
    JAMA; 2005 Oct; 294(13):1634-46. PubMed ID: 16204663
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Transforming Growth Factor Beta: structure, biologic effects and mechanism of action].
    Benzakour O
    Bull Cancer; 1994 Dec; 81(12):1014-22. PubMed ID: 7742590
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Consequences of altered TGF-beta expression and responsiveness in breast cancer: evidence for autocrine and paracrine effects.
    Tobin SW; Douville K; Benbow U; Brinckerhoff CE; Memoli VA; Arrick BA
    Oncogene; 2002 Jan; 21(1):108-18. PubMed ID: 11791181
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Mechanism of resistance to growth inhibition by transforming growth factor-beta 1 (TGF-beta 1) in primary lung cancer and new molecular targets in therapy].
    Gemma A; Uematsu K; Hagiwara K; Takenoshita S; Kudoh S
    Gan To Kagaku Ryoho; 2000 Jul; 27(8):1253-9. PubMed ID: 10945024
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Receptors for the TGF-beta ligand family.
    Bassing CH; Yingling JM; Wang XF
    Vitam Horm; 1994; 48():111-56. PubMed ID: 7941425
    [No Abstract]   [Full Text] [Related]  

  • 40. Transforming growth factor-beta in breast cancer: a working hypothesis.
    Reiss M; Barcellos-Hoff MH
    Breast Cancer Res Treat; 1997 Aug; 45(1):81-95. PubMed ID: 9285120
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.